Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Black Diamond Therapeutics (BDTX) Interest Expenses (2020)

Black Diamond Therapeutics (BDTX) has disclosed Interest Expenses for 1 consecutive years, with $1000.0 as the latest value for Q2 2020.

  • For the quarter ending Q2 2020, Interest Expenses changed N/A year-over-year to $1000.0, compared with a TTM value of $1000.0 through Mar 2021, changed N/A, and an annual FY2020 reading of $1000.0, changed N/A over the prior year.
  • Interest Expenses was $1000.0 for Q2 2020 at Black Diamond Therapeutics.
  • Across five years, Interest Expenses topped out at $1000.0 in Q2 2020 and bottomed at $1000.0 in Q2 2020.